Over the past weeks, Neuraxpharm has been actively engaging with the global pharma community at major industry events — and we’re just getting started.
Recent Highlights
CPHI 2025 in Frankfurt: Three inspiring days of collaboration with more than 100 partners worldwide, exploring innovative solutions and reaffirming our shared commitment to advancing impactful therapies in CNS.
BIO-Europe: A cornerstone event for global biopharma partnerships, sparking collaboration and sharing insights among industry leaders.
Next Stop: Jefferies London Healthcare Conference: From 17–19 November, we’ll be at the Waldorf Hilton for Europe’s largest healthcare-dedicated conference. Contact us to schedule a meeting with our team.
Why Neuraxpharm?
We are a specialty pharmaceutical company focused on CNS, including psychiatric and neurological disorders.
- Fully invested pan-European platform with direct presence in 23+ countries and growing globally
- Headquarters in Germany and Spain, with manufacturing and R&D hubs driving successful CNS launches
- Strong Sales & Marketing organization close to key stakeholders
- Solid clinical and market access strategy to ensure reimbursed access for patients
- Flexible, CNS-specialized structure adapting to diverse business needs
- Expanding presence outside the EU, proving the success of our launches in emerging markets
Our Portfolio
- Broad CNS range covering epilepsy, psychosis, schizophrenia, depression, anxiety, multiple sclerosis, and more
- 90% of our sales in CNS, reflecting deep expertise and commitment
- Innovation-driven: from generics and value-added medicines to originator brands, orphan drugs, biologics, and beyond-the-pill solutions — providing a wide range of proven and differentiated treatment options to meet all patients’ and HCPs’ needs
Our purpose is clear: to improve lives and well-being every day through specialized CNS therapeutic solutions.
This proven experience and capability within the complexity of the European market make us the partner of choice for CNS products in Europe.
Let’s keep building the future of CNS together.
Find out more on https://www.neuraxpharm.com/partner-of-choice/